$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[미국특허] Delayed-release glucocorticoid treatment of rheumatoid disease 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/22
  • A61K-009/48
  • A61P-019/02
  • C07J-005/00
  • A61K-045/06
  • A61K-031/573
  • A61K-009/28
출원번호 US-0860015 (2013-04-10)
등록번호 US-8920838 (2014-12-30)
발명자 / 주소
  • Schaeffler, Achim
출원인 / 주소
  • Horizon Pharma AG
인용정보 피인용 횟수 : 1  인용 특허 : 67

초록

Provided are methods for the treatment of a rheumatic disease, such as rheumatoid arthritis, ankylosating spondylitis and/or polymyalgia rheumatic, by administering a delayed-release dosage form of a glucocorticoid to a subject in need thereof wherein the treatment is administered once daily for at

대표청구항

1. A method for the treatment of a patient suffering from signs and symptoms of an underlying rheumatic disease and/or osteoarthritis, which comprises administering to said patient an effective amount of prednisone contained in a delayed-release dosage form, wherein said treatment is administered on

이 특허에 인용된 특허 (67) 인용/피인용 타임라인 분석

  1. Kolter, Karl; Schonherr, Michael; Ascherl, Hermann, Active ingredient-containing floating forms comprising polyvinyl acetate and polyvinylpyrrolidone, their use and production.
  2. Greissinger Dieter (Bad Homburg DEX) Kniesel Heidermarie (Blankenbach DEX) Heimbeck Winfried (Mmbris DEX) Tanner Herbert (Hanau DEX), Active-substance preparation for oral administration, especially to ruminants.
  3. Bogue,Beuford Arlie, Amorphous drug beads.
  4. Jurgens ; Jr. Raymond W. (Roswell GA) Graben Roger D. (Powder Springs GA) Sabir Adnan S. (Marietta GA), Bilayered oral pharmaceutical composition with pH dependent release.
  5. Shefer, Adi; Shefer, Shmuel David, Biodegradable bioadhesive controlled release system of nano-particles for oral care products.
  6. Mehta, Atul M., Chrono delivery formulations and method of use thereof.
  7. Chen Feng-Jing ; Patel Mahesh V., Clear oil-containing pharmaceutical compositions.
  8. Chen, Feng-Jing; Patel, Mahesh V.; Fikstad, David T., Clear oil-containing pharmaceutical compositions containing a therapeutic agent.
  9. Ayres, James W., Coated, platform-generating tablet.
  10. Halskov S.o slashed.ren,DKX ; Jepsen Svenn Kluver,DKX, Compositions for use in the regulation of subnormal pH values in the intestinal tract and for treatment of bowel disease.
  11. Cooper, Eugene R.; Ruddy, Stephen B., Compositions having a combination of immediate release and controlled release characteristics.
  12. Harinderpal Chhabra ; Shyamal K. Sarkar, Controlled onset and sustained release dosage forms and the preparation thereof.
  13. Staniforth John N. (Bath GB2), Controlled release device with an impermeable coating having an orifice for release of drug.
  14. Dandiker Yogendra (Ware GB3) Huckle Paul D. (Ware GB3), Controlled release pharmaceutical compositions.
  15. Hazel Judith Bardsley GB, Corticosteroid formulation.
  16. Bardsley, Hazel Judith; Bannister, Robin Mark; Gilbert, Julian Clive, Corticosteroid formulation comprising less than 2.5 mg prednisolone for once daily administration.
  17. Vergnault, Guy; Grenier, Pascal; Dragan, Christophe, Delayed release tablet with defined core geometry.
  18. Vergnault, Guy; Grenier, Pascal; Dragan, Christophe, Delayed release tablet with defined core geometry.
  19. Vergnault, Guy; Grenier, Pascal; Dragan, Christophe, Delayed release tablet with defined core geometry.
  20. Thurn-Mller Angelika (Frankenthal NY DEX) Hollenberg Jane (New York NY) Scott Ian (Scarsdale NY), Deposition of cosmetically functional material onto pigments and fillers.
  21. Schopflin Gisela (Berlin DT), Drug excipient of silicone rubber.
  22. van Lengerich Bernhard H., Embedding and encapsulation of controlled release particles.
  23. van Lengerich,Bernhard H., Encapsulation of sensitive liquid components into a matrix to obtain discrete shelf-stable particles.
  24. Dudhara, Kamlesh Mohanlal; Dharmadhikari, Nitin Bhalachandra; Dhavse, Vaishali Vijay, Gastric retention controlled drug delivery system.
  25. Lerner E. Itzhak,ILX ; Flashner Moshe,ILX ; Penhasi Adel,ILX, Gastrointestinal drug delivery system.
  26. Loew Dieter (Wuppertal DEX) Schuster Otto (Frankfurt DEX) Lukas H. (Frankfurt DEX), Ibuprofen-containing medicament.
  27. Frisbee Steven E. ; Barrow Deirdre M. ; Cascone Joseph ; McCarthy Barry D. ; Kiernan Bernard M. ; Anwar Hanan S., Immediate release dosage forms containing microspheres.
  28. Schner Wolfgang (Hainholzweg 20 3400 Gottingen DEX), Implantable catheter made of high cold flow material.
  29. Andrew L. Abrams ; Anand V. Gumaste, Metering and packaging of controlled release medication.
  30. Calanchi Massimo,ITX ; Zema Marco,ITX ; Brunetti Gabriele,ITX ; Giorgetti Enzo,ITX, Method for targeted and controlled release of drugs in the intestinal tract and more particularly in the colon.
  31. Del Corral L. Fernando ; Jaquess Percy A. ; Puckett Wallace E. ; Fues Russel E., Method of making tabletized ionene polymers.
  32. Kochinke,Frank, Methods and drug delivery systems for the treatment of orofacial diseases.
  33. Busetti Cesare,ITX ; Crimella Tiziano,ITX, Methods for treating early morning pathologies.
  34. Busetti,Cesare; Crimella,Tiziano, Methods for treating early morning pathologies.
  35. Hirsh, Jane C.; Rariy, Roman V.; Chungi, Shubha; Rao, Srinivas G.; Heffernan, Michael T., Modified release compositions of milnacipran.
  36. Oberegger,Werner; Zhou,Fang; Maes,Paul; Turchetta,Stefano; Jackson,Graham; Massardo,Pietro; Saleh,Mohammad Ashty, Modified release formulations of a bupropion salt.
  37. Shefer, Adi; Shefer, Samuel David, Multi component controlled release system for oral care, food products, nutraceutical, and beverages.
  38. Griffin David (1 Paddington Cir. Bronxville NY 10708), Multi-stage delivery system for ingestible medications or nutrients.
  39. Shefer, Adi; Shefer, Shmuel David, Multicomponent biodegradable bioadhesive controlled release system for oral care products.
  40. Ting, Richard; Hsiao, Charles, Multiplex drug delivery system suitable for oral administration.
  41. Sharma Shri C. (Mendham NJ) Shaw James J. (Morristown NJ) Yang Robert K. (Morris Plains NJ), Novel drug delivery system.
  42. Van Balken Paulus M.,NLX ; Elbers Jules A. C.,NLX ; Frijlink Henderik W.,NLX ; Philips Wienman E.,NLX, Oral delayed immediate release formulation and method for preparing the same.
  43. Wright, IV,Curtis; Carpanzano,Anthony E., Oral dosage form comprising a therapeutic agent and an adverse-effect agent.
  44. Iamartino Piero (Monza ITX) Maffione Grazia (Milan ITX) Pontello Lino (Milan ITX), Orally-pharmaceutical preparations with colon selective delivery.
  45. Faour, Joaquina, Osmotic device having a preformed passageway that increases in size.
  46. Guglielmotti Angelo,ITX ; Dionisio Paolo,ITX, Pharmaceutical composition for the treatment of autoimmune diseases.
  47. Arbuthnot Gordon Nelson ; Lomas Karen Klapper ; Meyer Glenn Alan, Pharmaceutical formulation.
  48. Conte Ubaldo,ITX ; Maggi Lauretta,ITX, Pharmaceutical tablet suitable to deliver the active substance in subsequent and predeterminable times.
  49. Conte Ubaldo (Busto Arsizio ITX) La Manna Aldo (Pavia ITX) Maggi Lauretta (Pavia ITX), Pharmaceutical tablets releasing the active substance after a definite period of time.
  50. Giannini Robert P. (Plantation FL) Goodstein Stephen (Plantation FL), Prednisone microencapsulated granules.
  51. Kolter,Karl; Flick,Dieter; Ascherl,Hermann, Process for producing solid oral dosage forms with sustained release of active ingredient.
  52. Pozzi Franco (Como ITX) Furlani Pia (Milan ITX), Programmed release oral solid pharmaceutical dosage form.
  53. Wolfgang A. Ritschel ; Mukul A. Agrawal, Self-destructing, controlled release peroral drug delivery system.
  54. Patel Mahesh V. ; Chen Feng-Jing, Solid carriers for improved delivery of active ingredients in pharmaceutical compositions.
  55. Niels P. Ryde ; Stephen B. Ruddy, Solid dose nanoparticulate compositions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate.
  56. Heafield Joanne (Cambridge GBX) Leslie Stewart T. (Cambridge GBX) Malkowska Sandra T. A. (Cambridge GBX) Neale Philip J. (Cambridge GBX), Spheroids.
  57. Hallgren Roger,SEX, Sustained release glucocorticoid pharmaceutical composition.
  58. Jian Hwa Guo ; George William Skinner, Sustained release polymer blend for pharmaceutical applications.
  59. Skinner George William, Sustained release polymer blend for pharmaceutical applications.
  60. Skinner George William, Sustained release polymer blend for pharmaceutical applications.
  61. Conte Ubaldo (Busto Arsizio ITX) La Manna Aldo (Pavia ITX) Colombo Paolo (Pavia ITX), Tablet for pharmaceutical use able to release active substances at successive times.
  62. Ueda Yoshio (Kobe JPX) Hata Takehisa (Muko JPX) Yamaguchi Hisami (Nishinomiya JPX) Ueda Satoshi (Kawanishi JPX) Kodani Masateru (Ikeda JPX), Time-controlled explosion systems and processes for preparing the same.
  63. McGuire James L. (Stanford CA) Van Vollenhoven Ronald F. (Stanford CA) Engleman Edgar G. (Stanford CA), Treatment of systemic lupus erythematosus with dehydroepiandrosterone.
  64. Patel Mahesh V. ; Chen Feng-Jing, Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents.
  65. Patel Mahesh V. ; Chen Feng-Jing, Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents.
  66. Matoba Hiroshi (Osaka JPX) Koyama Hiroyoshi (Mishima JPX) Kikuta Jun-ichi (Suita JPX), Uncoated tablets and method of producing the same.
  67. Patel Suryakant Dahyabhai (The Wellcome Foundation Limited ; Temple Hill Dartford ; Kent ; Da1 5AH GBX) Gamlen Michael John Desmond (The Wellcome Foundation Limited ; Temple Hill Dartford ; Kent ; Da, Water-dispersible tablets.

이 특허를 인용한 특허 (1) 인용/피인용 타임라인 분석

  1. Schaeffler, Achim, Delayed-release glucocorticoid treatment of rheumatoid disease.

활용도 분석정보

상세보기
다운로드
내보내기

활용도 Top5 특허

해당 특허가 속한 카테고리에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로